First Command Bank Abb Vie Inc. Transaction History

First Command Bank

$1.06 Billion
Q2 2023

A detailed history of First Command Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, First Command Bank holds 5,057 shares of ABBV stock, worth $991,525. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,057

Previous 5,366 5.76%

Holding current value

$991,525

Previous $855,000 20.35%

% of portfolio

0.06%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $40,945 - $50,954	-309 Reduced 5.76%	5,057 $681,000
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $76,064 - $87,600	-526 Reduced 8.93%	5,366 $855,000
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $5,117 - $6,137	37 Added 0.63%	5,892 $952,000
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $35,834 - $41,099	-267 Reduced 4.36%	5,855 $786,000
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $27,524 - $34,992	200 Added 3.38%	6,122 $938,000
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $117,726 - $146,065	892 Added 17.73%	5,922 $960,000
Q3 2021 Dec 16, 2021	BUY	$106.4 - $120.78 $50,008 - $56,766	470 Added 10.31%	5,030 $543,000
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 2.15%	4,560 $513,000
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $40,920 - $45,048	-400 Reduced 7.91%	4,660 $504,000
Q4 2020 Jan 19, 2021	SELL	$80.49 - $108.67 $37,830 - $51,074	-470 Reduced 8.5%	5,060 $542,000
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $144,500 - $169,596	1,682 Added 43.71%	5,530 $484,000
Q2 2020 Jul 17, 2020	SELL	$73.37 - $98.18 $6,309 - $8,443	-86 Reduced 2.19%	3,848 $378,000
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $451 - $684	-7 Reduced 0.18%	3,934 $299,000
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $3,245 - $4,061	-45 Reduced 1.13%	3,941 $349,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $13,414 - $16,128	213 Added 5.65%	3,986 $302,000
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $3,613 - $4,618	-55 Reduced 1.44%	3,773 $274,000
Q1 2019 Apr 17, 2019	SELL	$77.14 - $90.79 $52,455 - $61,737	-680 Reduced 15.08%	3,828 $308,000
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $219,459 - $270,652	2,819 Added 166.9%	4,508 $416,000
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $19,560 - $21,744	220 Added 14.98%	1,689 $159,000
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $10,234 - $12,110	-114 Reduced 7.2%	1,469 $136,000
Q1 2018 Apr 12, 2018	BUY	$92.01 - $123.21 $8,648 - $11,581	94 Added 6.31%	1,583 $0
Q4 2017 Jan 12, 2018	SELL	$89.56 - $98.21 $4,657 - $5,106	-52 Reduced 3.37%	1,489 $144,000
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $107,638 - $137,488	1,541	1,541 $137,000

Others Institutions Holding ABBV

# of Institutions

4,189

Shares Held

1.29B

Call Options Held

17.1M

Put Options Held

15.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Command Bank with notifications on news.

Account

First Command Bank Abb Vie Inc. Transaction History